BE Study of the Combinations of Gemigliptin 50mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone

NCT02670070 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: gemigliptin 50mg, rosuvastatin 20mg

Sponsor

LG Life Sciences